Overview
Glooko is an enterprise-grade digital health platform that serves as a universal hub for diabetes and metabolic health data. By the year 2026, Glooko has solidified its position as the market leader in Remote Patient Monitoring (RPM) by leveraging AI-driven predictive insights to identify hypoglycemia and hyperglycemia trends before they occur. Its technical architecture centers on a hardware-agnostic data ingestion engine that synchronizes with over 95% of globally available insulin pumps, continuous glucose monitors (CGMs), and blood glucose meters. For clinicians, Glooko provides a high-density population health dashboard that integrates directly with major Electronic Health Records (EHR) such as Epic and Cerner via FHIR-based APIs. The platform utilizes proprietary algorithms to transform raw biometric data into actionable 'Glooko Reports,' which facilitate personalized therapeutic adjustments. In the 2026 landscape, Glooko is increasingly utilized not just for diabetes, but as a broader metabolic health monitoring tool, incorporating activity data from wearables and nutritional logs to provide a holistic view of patient health, effectively reducing hospital readmissions and optimizing clinical workflows for endocrinology practices worldwide.